Vanessa Quick

1.7k total citations
12 papers, 93 citations indexed

About

Vanessa Quick is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Vanessa Quick has authored 12 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Nephrology. Recurrent topics in Vanessa Quick's work include Vasculitis and related conditions (7 papers), Otitis Media and Relapsing Polychondritis (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Vanessa Quick is often cited by papers focused on Vasculitis and related conditions (7 papers), Otitis Media and Relapsing Polychondritis (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Vanessa Quick collaborates with scholars based in United Kingdom and United States. Vanessa Quick's co-authors include Susan P. Mollan, Hannah Lyons, Alexandra J. Sinclair, John Kirwan, Ann W Morgan, Luke Flower, Daniel Fishman, Jessica Manson, Li Chen and Malcolm Boyce and has published in prestigious journals such as Lara D. Veeken, British Journal of Clinical Pharmacology and Eye.

In The Last Decade

Vanessa Quick

12 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Quick United Kingdom 5 58 45 19 18 15 12 93
N. Bulanov Russia 7 71 1.2× 44 1.0× 26 1.4× 29 1.6× 5 0.3× 57 163
G. Richard-Colmant France 5 25 0.4× 27 0.6× 11 0.6× 12 0.7× 50 3.3× 6 96
Alexis Régent France 2 70 1.2× 44 1.0× 17 0.9× 30 1.7× 10 0.7× 2 86
Alice Bartoletti Italy 3 40 0.7× 29 0.6× 11 0.6× 10 0.6× 8 0.5× 8 52
Elisa Bellis Italy 4 47 0.8× 57 1.3× 12 0.6× 16 0.9× 8 0.5× 15 84
Marcin Milchert Poland 5 44 0.8× 35 0.8× 27 1.4× 8 0.4× 2 0.1× 26 78
Elvira Mora Spain 7 14 0.2× 37 0.8× 20 1.1× 25 1.4× 13 0.9× 24 121
Sabine Revuz France 6 36 0.6× 14 0.3× 16 0.8× 6 0.3× 6 0.4× 9 74
Vivien Guillotin France 4 15 0.3× 52 1.2× 4 0.2× 45 2.5× 4 0.3× 9 121
N. Vegas-Revenga Spain 6 24 0.4× 79 1.8× 3 0.2× 27 1.5× 19 1.3× 11 114

Countries citing papers authored by Vanessa Quick

Since Specialization
Citations

This map shows the geographic impact of Vanessa Quick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Quick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Quick more than expected).

Fields of papers citing papers by Vanessa Quick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Quick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Quick. The network helps show where Vanessa Quick may publish in the future.

Co-authorship network of co-authors of Vanessa Quick

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Quick. A scholar is included among the top collaborators of Vanessa Quick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Quick. Vanessa Quick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Quick, Vanessa, et al.. (2024). Life after tocilizumab given for giant cell arteritis: a patient survey and argument for re-treatment. Rheumatology Advances in Practice. 8(2). rkae054–rkae054. 1 indexed citations
2.
Flower, Luke, Maryam Khosravi, Jim Buckley, et al.. (2021). Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case series. The Lancet Rheumatology. 3(11). e744–e747. 6 indexed citations
3.
4.
Flower, Luke, et al.. (2020). O01 Adult onset PIMS-TS with secondary haemophagocytic lymphistiocytosis: into the eye of the cytokine storm. Rheumatology Advances in Practice. 4(Supplement_1). 2 indexed citations
5.
Quick, Vanessa, et al.. (2020). P180 External validation of the Southend GCA Probability Score (GCAPS) as a screening tool for referrals with possible GCA. Lara D. Veeken. 59(Supplement_2). 2 indexed citations
6.
Lyons, Hannah, et al.. (2019). A new era for giant cell arteritis. Eye. 34(6). 1013–1026. 43 indexed citations
7.
Mollan, Susan P., et al.. (2019). Rapid visual recovery following intravenous tocilizumab in glucocorticoid resistant refractory giant cell arteritis. BMJ Case Reports. 12(10). e229236–e229236. 7 indexed citations
8.
Quick, Vanessa, et al.. (2018). 149 All patients with possible giant cell arteritis should be seen by a rheumatologist before temporal artery biopsy. Lara D. Veeken. 57(suppl_3). 1 indexed citations
10.
Quick, Vanessa, et al.. (2014). 11. A Case of Amyloid Angiopathy Mimicking Giant Cell Arteritis. Lara D. Veeken. 53(suppl_1). i60–i60. 2 indexed citations
11.
Ferbas, John, Michelle Horner, Arunan Kaliyaperumal, et al.. (2013). A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus. British Journal of Clinical Pharmacology. 76(2). 188–202. 14 indexed citations
12.
Quick, Vanessa & John Kirwan. (2012). Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell (temporal) arteritis. The Journal of the Royal College of Physicians of Edinburgh. 42(4). 341–349. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026